| Structure |
Chemical Name |
CAS |
MF |
 |
Ambroxol Imp.O |
1807328-39-7 |
C13H12Br2N2O |
 |
(S)-PYRROLIDINE-2-CARBONITRILE |
204387-53-1 |
C5H8N2 |
 |
Ticagrelor Intermediate 1 D-Tartrate |
2376278-72-5 |
C14H25NO10 |
 |
2-Keto ZolpideM |
400038-68-8 |
C19H19N3O2 |
 |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
 |
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
 |
LCZ696(valsartan + sacubitril) impurity 34 |
|
|
 |
Erlotinib IMpurity C |
1312937-41-9 |
C15H20N2O5 |
 |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel- |
2124277-87-6 |
C17H17Cl2N |
|
|
Carbocistein Impurity B |
|
|
|
|
Pitavastatin Impurity 71 |
|
|
|
|
Saxagliptin Impurity 5 |
|
|
|
|
Atorvastatin Impurity N(Calcium salt |
|
|
|
|
Pitavastatin Impurity 104 |
|
|
|
|
Atracurium Impurity H Complete Set |
|
|
|
|
(2R,3S,4R,5R,6S)-2-((R)-1,2-dihydroxyethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
Phenylephrine Impurity 2 |
|
C9H13NO2 |
![4'-hydroxy-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid](/CAS/20200611/GIF/1097777-60-0.gif) |
4'-hydroxy-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid |
1097777-60-0 |
C13H9NO5 |
 |
ethyl 2-(4-(sec-butoxy)-3-formylphenyl)-4-methylthiazole-5-
carboxylate |
2375033-31-9 |
C18H21NO4S |
|
|
lansoprazole Impurity 23 |
|
|
|
|
Cabozantinib impurity 44 |
|
|
|
|
Trelagliptin Impurity 22 |
|
|
 |
TOPOTECANACETATE |
123948-88-9 |
C25H27N3O7 |
 |
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
 |
9H-3,9'-bicarbazole-1,1',2,2',3',4,4',5,5',6,6',7,7',8,8'-d15 |
2778147-33-2 |
C24H16N2 |
 |
p-トリルグリシジルエーテル |
2186-24-5 |
C10H12O2 |
 |
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
![7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine](/CAS/20130318/GIF/CB72621905.gif) |
7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine |
1379666-94-0 |
C18H17F6N5O2 |
 |
Avibactam Impurity 38 |
2241730-86-7 |
C20H29BrN2O5 |
|
|
Anastrozole Impurity IV |
|
|
|
|
Axitinib Impurity 18 |
|
|
 |
RS 42358-197 |
135729-55-4 |
C19H23ClN2O |
 |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
 |
Adrenaline IMpurity F |
78995-75-2 |
C9H13NO5S |
|
|
Febuxostat Impurity 81 |
|
|
|
|
Lenvatinib Impurity 21 |
|
|
|
|
Fulvestrant impurity G |
|
|
 |
(S)-Alogliptin Benzoate Salt |
1638544-64-5 |
C25H27N5O4 |
 |
Palonosetron Impurity 11 |
2216753-67-0 |
C18H24N2O |
|
|
Peramivir Intermediate Impurity 39 |
|
|
 |
2-ヒドロキシ-2-(チオフェン-2-イル)-2-(チオフェン-3-イル)酢酸メチル |
28748-67-6 |
C11H10O3S2 |
|
|
Empagliflozin Impurity 22 |
|
|
|
|
Butyphthalide impurity 50 |
|
|
 |
TWEORVZIMOFLDE-MXTNKPTQSA-N |
1706671-50-2 |
C25H31N5O9S |
|
|
Eltrombopag Impurity 3 |
|
|
|
|
Amoxicillin related impurities K |
|
|
|
|
(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole |
|
|
 |
4-TERT-ブチル-2,6-ジメチル-3-ヒドロキシフェニルアセトアミド(OXYMETAZOLINE IMPURITY) |
55699-13-3 |
C14H21NO2 |
|
|
Imimidistine impurity B |
|
|
|
|
Azacitidine Impurity 3 |
|
|
 |
Febuxostat Impurity 130 |
1643131-93-4 |
C20H25NO5S |
 |
Amoxicillin Impurity P |
|
C16H19N3O5S |
 |
Sunitinib iMpurity |
356068-98-9 |
C12H19N3O2 |
 |
2-hexanoylbenzoic acid |
857538-11-5 |
C13H16O3 |
|
|
Cephalexin Open-Ring Impurity |
|
|
 |
4-(4-フルオロフェニル)-2-シクロプロピルキノリン-3-カルボン酸メチルエステル |
121659-86-7 |
C20H16FNO2 |
 |
Amoxicillin Impurity U |
|
C16H19N3O5S |
![β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-](/CAS/GIF/932042-85-8.gif) |
β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- |
932042-85-8 |
C47H53NO15 |
|
|
(S)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
 |
3-Isoquinolinecarboxylic acid, 7-(4-chlorophenoxy)-4-hydroxy-, methyl ester |
2711953-58-9 |
C17H12ClNO4 |
|
|
Nitrendipine Impurity 4 |
|
|
 |
MeropeneM iMpurity |
96035-23-3 |
C15H19N3O5S |
 |
Lisinopril EP Impurity G |
1356839-89-8 |
C42H60N6O9 |
|
|
Tegoprazan Impurity 14 |
|
|
|
|
Olodaterol Impurity 32 |
|
|
|
|
Posaconazole Impurity 74 |
|
|
![(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (Levofloxacin IMpurity)](/CAS/20150408/GIF/106939-30-4.gif) |
(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (Levofloxacin IMpurity) |
106939-30-4 |
C19H22FN3O4 |
 |
Vildagliptin Impurity 31 |
119694-48-3 |
C10H14N4O6 |
 |
Amoxicillin Impurity Z |
|
C16H19N3O5S |
|
|
Peramivir Guanidine Acetyl Positional Heterogeneous Impurities |
|
|
 |
Apixaban Impurity 73 |
1998079-13-2 |
C44H40N8O8 |
 |
Dapoxetine impurity |
126113-24-4 |
C19H16O2 |
|
|
Ezetimibe Impurity 36 |
|
|
|
|
(2S,3R,4R,5S,6R)-2-(4-bromo-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
2-bromo-1-(4-chlorothiophen-2-yl)ethanone |
677007-73-7 |
C6H4BrClOS |
|
|
Apixaban impurity 66S |
|
|
|
|
Rivaroxaban Impurity 19 |
|
|
![4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸](/CAS/GIF/114176-52-2.gif) |
4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸 |
114176-52-2 |
C12H18N2O3S |
 |
(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル |
86153-39-1 |
C20H25NO3 |
|
|
Pemetrexed disodium Impurity 30 |
|
|
|
|
(Glu3)-Carbetocin (Impurity D) |
|
|
|
|
Empagliflozin Impurity 108 |
|
|
![3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-](/CAS/20210111/GIF/2468737-94-0.gif) |
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-94-0 |
C24H25Cl2N5O3 |
 |
Peramivir Impurity 7 HCl |
1352062-19-1 |
C14H27ClN2O4 |
|
|
Capecitabine impurity 6 |
|
|
|
|
Aprepitant Impurity 28 |
|
|
|
|
Bortezomib Impurity 19 |
|
|
 |
Fludarabine EP impurity H |
548774-57-8 |
C10H10FN5O3 |
|
|
Silodosin Impurity B |
|
|
|
|
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
|
|
Adsorption of hydrogen sulfide Adsorption of impurities in water filter material |
|
|
 |
Bilastine N-Oxide |
2069238-47-5 |
C28H37N3O4 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate](/CAS/20180702/GIF/CB22995784.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
 |
N-(2,4-ジクロロ-5-ヒドロキシフェニル)アセトアミド |
67669-19-6 |
C8H7Cl2NO2 |
 |
TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE |
404958-08-3 |
C10H17ClO4 |
|
|
Vonohra pyrrole nitrogen oxide |
|
|
 |
Apalutamide Acid Impurity |
1332391-04-4 |
C20H12F4N4O3S |
|
|
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|
 |
Olanzapine impurity O |
|
C17H20N4S |
![(Z)-1-(4-ヒドロキシフェニル)-1-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-2-フェニル-1-ブテン](/CAS/GIF/65213-48-1.gif) |
(Z)-1-(4-ヒドロキシフェニル)-1-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-2-フェニル-1-ブテン |
65213-48-1 |
C26H29NO2 |